According to the latest report by IMARC Group, titled “Opioid Use Disorder Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2033,” the global opioid use disorder market size is witnessing steady growth. Opioid use disorder (OUD) is a medical condition characterized by compulsive drug seeking and use. It comprises prescription painkillers, such as oxycodone and hydrocodone, and illegal drugs. It is associated with intense cravings for opioids, continued use despite negative consequences, withdrawal symptoms when attempting to quit, tolerance, and difficulty controlling or reducing use. It is diagnosed through a comprehensive evaluation of healthcare professionals, such as physical exams, laboratory tests, and a review of the medical and substance use history of patients. It is treated using behavioral therapy and medications, such as methadone and buprenorphine, to help patients address the underlying psychological and social factors that contribute to their addiction.
Global Opioid Use Disorder Market Trends:
At present, the increasing prevalence of opioid addiction represents one of the major factors driving the demand for opioid use disorder treatment. Moreover, the rising adoption of naloxone and medication assisted treatment (MAT) for treating opioid use disorder on account of its several associated benefits, which include improved outcomes, reduced risk of relapse, and increased likelihood of long-term recovery, is currently favoring the growth of the market. In addition, governing agencies of numerous countries are undertaking initiatives to address the opioid epidemic by funding addiction treatment programs and introducing regulatory steps to limit opioid prescriptions. They are also taking measures to offer quality healthcare facilities that are accessible to all. Besides this, governing agencies are investing in research and development (R&D) activities to develop new treatments and formulations like long-acting injectables and implantable devices that offer longer-lasting relief from opioid withdrawal symptoms and cravings. This, along with significant improvements in the diagnostic technologies, is contributing to the market growth. Apart from this, the growing number of rehabilitation centers is creating a positive outlook for the market.
- Region-wise, the market has been classified into United States, EU5 (Germany, France, United Kingdom, Italy, Spain), and Japan. The United States has the largest patient population for opioid use disorder and also represents the largest market for its treatment among the seven major markets.
- This research study also offers a thorough overview of late-stage pipeline candidates and currently marketed medications for opioid use disorder.
- The study also offers a thorough overview of the treatment practices for opioid use disorder, the share of specific therapies, and the performance of key market players.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
134 N 4th St.
Brooklyn, NY 11249, USA
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800